Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects

被引:44
作者
Kim, Soon Sun [1 ]
Cho, Hyo Jung [1 ]
Kim, Hyun Ji [2 ]
Kang, Dae Ryong [3 ]
Berry, Jacob R. [4 ]
Kim, Jin Hong [1 ]
Yang, Min Jae [1 ]
Lim, Sun Gyo [1 ]
Kim, SooJin [2 ]
Cheong, Jae Youn [1 ]
Cho, Sung Won [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Gastroenterol, 164 Worldcup Ro, Suwon 16499, Gyeonggi Do, South Korea
[2] Ajou Univ, Sch Med, Off Biostat, Suwon, South Korea
[3] Ajou Univ, Sch Med, Dept Med Humanities & Social Med, Suwon, South Korea
[4] Osan Air Base, TH Fight Squadron 25, Osan, South Korea
关键词
Insulin resistance; Metabolic syndrome; Obesity; INSULIN-RESISTANCE; FIBROSIS SCORE; INCREASED RISK; ASSOCIATION; NAFLD; JAPANESE; OBESITY; PREVALENCE; PARAMETERS; STEATOSIS;
D O I
10.1016/j.dld.2017.12.018
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Non alcoholic fatty liver disease (NAFLD) is associated with substantial cardiometabolic morbidity. Aims: We evaluated the long-term extrahepatic complications of NAFLD and sought to evaluate NAFLD in non-obese subjects. Methods: A total of 2920 participants were retrospectively selected from a health check-up center in 2000, and followed through to December 2010. NAFLD was diagnosed using ultrasonography. Subjects were stratified according to body mass index, NAFLD, and metabolic syndrome. Results: The prevalence of non-obese NAFLD subjects and metabolically unhealthy non-obese subjects was 14.4% and 8.7%, respectively. In the multivariate analysis, non-obese NAFLD subjects had a significantly higher risk for diabetes mellitus (DM; HR 2.69, 95% CI 1.72-4.20, P < 0.001); no increase was observed for hypertension or cardiovascular disease. Metabolically unhealthy non-obese subjects had a significantly higher risk for hypertension (HR 2.75, 95% CI 2.02-3.74, P<0.001), DM (HR 5.72, 95% CI 3.68-8.89, P<0.001), and cardiovascular disease (HR 2.93, 95% CI 1.53-5.63,P = 0.001). Subgroup analysis of non-obese subjects showed that NAFLD, without metabolic syndrome, conferred a higher risk for DM (HR 3.60, 95% CI 2.03-6.39, P<0.001). Conclusion: Non-obese subjects with NAFLD are at a higher risk for DM independent of metabolic syndrome. (C) 2017 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 64 条
[1]  
Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI [10.2337/dc13-S011, 10.2337/dc12-1631]
[2]   The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[3]  
[Anonymous], 2000, AS PAC PERSP RED OB
[4]   Combined Effect of Nonalcoholic Fatty Liver Disease and Impaired Fasting Glucose on the Development of Type 2 Diabetes A 4-year retrospective longitudinal study [J].
Bae, Ji Cheol ;
Rhee, Eun Jung ;
Lee, Won Young ;
Park, Se Eun ;
Park, Cheol Young ;
Oh, Ki Won ;
Park, Sung Woo ;
Kim, Sun Woo .
DIABETES CARE, 2011, 34 (03) :727-729
[5]   Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases [J].
Ballestri, Stefano ;
Nascimbeni, Fabio ;
Baldelli, Enrica ;
Marrazzo, Alessandra ;
Romagnoli, Dante ;
Targher, Giovanni ;
Lonardo, Amedeo .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 72 :57-65
[6]   Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection-Liver: The "Musketeer" in the Spotlight [J].
Ballestri, Stefano ;
Nascimbeni, Fabio ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Targher, Giovanni ;
Lonardo, Amedeo .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (03)
[7]   Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis [J].
Ballestri, Stefano ;
Zona, Stefano ;
Targher, Giovanni ;
Romagnoli, Dante ;
Baldelli, Enrica ;
Nascimbeni, Fabio ;
Roverato, Alberto ;
Guaraldi, Giovanni ;
Lonardo, Amedeo .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 (05) :936-944
[8]   Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications [J].
Ballestri, Stefano ;
Romagnoli, Dante ;
Nascimbeni, Fabio ;
Francica, Giampiero ;
Lonardo, Amedeo .
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (05) :603-627
[9]   Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD [J].
Ballestri, Stefano ;
Lonardo, Amedeo ;
Romagnoli, Dante ;
Carulli, Lucia ;
Losi, Luisa ;
Day, Christopher P. ;
Loria, Paola .
LIVER INTERNATIONAL, 2012, 32 (08) :1242-1252
[10]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)